Clinical Trials Directory

Trials / Completed

CompletedNCT03413098

The Evaluation of a Novel Nasal Mask for the Treatment of Obstructive Sleep Apnea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Fisher and Paykel Healthcare · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This investigation is a prospective, non randomized, non blinded study. This investigation is designed to evaluate the performance, comfort and ease of use with the F\&P trial nasal mask amongst Obstructive Sleep Apnea (OSA) patients.

Detailed description

Visit 1 will involve the participants consented in to the trial. Visit 2 will involve the participants being fitted with the F\&P trial nasal mask for use in-home. The participant will then come in to return the mask (Visit Three) and have a final interview, this ensures the maximum time participants will be exposed to the trial mask in home will be 14 ± 4 days from visit two. The mask will be returned to the Institution at the conclusion of the trial and the participant will return to their previous mask. The Institution will recruit all patients within 1 week of the beginning of the study.

Conditions

Interventions

TypeNameDescription
DEVICENasal CPAP maskInvestigative Nasal Mask to be used for OSA therapy

Timeline

Start date
2018-02-12
Primary completion
2018-03-09
Completion
2018-03-09
First posted
2018-01-29
Last updated
2018-03-22

Locations

2 sites across 1 country: New Zealand

Source: ClinicalTrials.gov record NCT03413098. Inclusion in this directory is not an endorsement.

The Evaluation of a Novel Nasal Mask for the Treatment of Obstructive Sleep Apnea (NCT03413098) · Clinical Trials Directory